15 Apr 2026
Immunotherapy “stop and go” and early discontinuation: A viable option in limited resources settingPublisher siteJournal of Oncology Pharmacy Practice, Cancer Immunotherapy and Biomarkers
Active, last published 2026
In global cancer incidence and screening
Myriam
Saadi
Scholar“Research focused on Global Cancer Incidence and Screening and adjacent fields.”
University of Tunis El Manar
Tunisia
Claim Your ProfileTunisia2
H-index
9
Citations
Myriam has not officially claimed their profile. If you are Myriam, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
yriam Saadi is a researcher working on Global Cancer Incidence and Screening. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Myriam's work has been cited 9 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Global Cancer Incidence and Screening×7Economic and Financial Impacts of Cancer×6Cancer survivorship and care×4Breast Cancer Treatment Studies×3Cancer Treatment and Pharmacology×3
04 · Where I am
Affiliations
Affiliation on published researchAbderrahmane Mami Hospital, TunisiaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
8 works28 Jan 2026Open access
When Standards Meet Reality: An Inverted PORTEC-3 Protocol for High-Risk Endometrial Cancer in Resource-Limited SettingsPublisher siteCancers, Endometrial and Cervical Cancer Treatments
27 Dec 2025Open access
A decade of Non-Small Cell Lung Cancer management: threats and opportunities in resource-limited settingPublisher siteLa Tunisie Médicale, Lung Cancer Diagnosis and Treatment
1 Sept 2025
381P Utility of intensive follow-up regimen after breast cancer therapy according to CancerMath predictive modelPublisher siteAnnals of Oncology, Breast Cancer Treatment Studies
1 May 2025Open access
465P Beyond remission: The fear of recurrence among Tunisian breast cancer survivorsPublisher siteESMO Open, Multiple and Secondary Primary Cancers
1 May 2025Open access
379P Real-world experience of CDK4/6 Inhibitors in Tunisia: Can we safely stop and resume treatment?Publisher siteESMO Open, Advanced Breast Cancer Therapies
18 Mar 2025Open access
Durable disease control with cabozantinib in metastatic chromophobe renal cell carcinoma: A rare case with promising outcomesPublisher siteUrology Case Reports, Renal cell carcinoma treatment
5 Apr 20241cites
Navigating the Cancer Journey: Experiences and Perspectives of Young Adult Patients in TunisiaPublisher siteJournal of Adolescent and Young Adult Oncology, Economic and Financial Impacts of Cancer
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Myriam?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you